Header Logo

Connection

Jonathan Kay to Crohn Disease

Back to Details
This is a "connection" page, showing publications Jonathan Kay has written about Crohn Disease.
Jonathan Kay
Connection Strength
0.801
Crohn Disease
  1. Kay J, Cross RK, Feldman SR, Park Y, Hanauer SB. Review of Adalimumab Biosimilar SB5 in Immune-Mediated Inflammatory Diseases. Adv Ther. 2024 02; 41(2):509-533.
    View in: PubMed
    Score: 0.801
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.